Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. 8-K Event Results of operations
  2. 4 Grant or award EVP, Chief Business Officer acquired 19,118 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. 4 Open-market sale EVP, Chief Medical Officer sold 2,400 shares at an average $132.72 ($318,535)
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 4 Open-market sale EVP, Chief Medical Officer sold 2,400 shares at an average $128.44 ($308,249)
  9. 4 Open-market sale Director sold 2,500 shares at $119.55 ($298,875)
  10. 4 Open-market sale Director sold 10,000 shares at an average $130.54 ($1,305,391)
  11. 4 Option exercise EVP, Chief Medical Officer acquired 7,923 shares (option exercise)
  12. 4 Open-market sale EVP, Chief Medical Officer sold 2,400 shares at $149.81 ($359,544)
  13. 4 Open-market sale EVP, Chief Financial Officer sold 3,482 shares at $180.12 ($627,178)
  14. 4 Open-market sale President and CEO sold 121,372 shares at an average $160.83 ($19,520,418)
  15. 4 Open-market sale EVP, Chief Scientific Officer sold 97,000 shares at an average $154.83 ($15,018,054)
  16. 4 Open-market sale EVP, Chief Medical Officer sold 2,400 shares at an average $158.04 ($379,300)
  17. 4 Open-market sale EVP, Chief Financial Officer sold 30,000 shares at an average $159.45 ($4,783,538)
  18. 4 Open-market sale President and CEO sold 27,139 shares at an average $152.01 ($4,125,416)
  19. 4 Open-market sale President and CEO sold 22,682 shares at an average $151.28 ($3,431,398)
  20. 4 Open-market sale EVP, Chief Medical Officer sold 2,400 shares at $164.05 ($393,720)

Page 17 of 37 · 725 filings